The role of changes in systemic inflammatory response markers during neoadjuvant chemotherapy in predicting suboptimal surgery in ovarian cancer

Gulseren, VAROL; Cakir, Ilker; Ozdemir, Isa; Sanci, Muzaffer; Gokcu, Mehmet; Gungorduk, Kemal

doi:10.1016/j.currproblcancer.2020.100536

The role of changes in systemic inflammatory response markers during neoadjuvant chemotherapy in predicting suboptimal surgery in ovarian cancer

Atıf İçin Kopyala

Gulseren V., Cakir I., Ozdemir I. A., Sanci M., Gokcu M., Gungorduk K.

CURRENT PROBLEMS IN CANCER, cilt.44, sa.4, 2020 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 44 Sayı: 4
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.currproblcancer.2020.100536
Dergi Adı: CURRENT PROBLEMS IN CANCER
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
Erciyes Üniversitesi Adresli: Evet

Özet

Aim: The aim of this study was to investigate the possibility of using the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio, and platelet count and their dynamic changes during chemotherapy to predict suboptimal interval debulking surgery (IDS) in stage IIIC-IVA serous ovarian cancer (OC).